Did You Know?

Editor’s Picks

Latest News

Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress

Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse modelsCAMBRIDGE, Mass., Oct. 09,...

Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando

Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina Subspecialty DayCAMBRIDGE,...

IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa

Partners will advance end-to-end development of biologics for regionally prioritized diseases starting with Mpox and HIV CAIRO, EGYPT; BERLIN, GERMANY;...

Addison Care Debuts at athenahealth 2025 Thrive Conference: 3D Virtual Caregiver Tackles Global Healthcare Crisis of Non-Adherence and Workforce Shortages

LAS CRUCES, NEW MEXICO / ACCESS Newswire / October 9, 2025 / The healthcare industry is approaching a breaking point....

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research

New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development.  FREMONT, Calif., Oct. 9,...

AHIMA 2025: The 20 Must-See Exhibitors With Top User Scores and Future-Focused HIM Innovations Identified by Black Book Surveys

Highlighting the Solutions Transforming Data Accuracy, Automation, and AI-Driven Revenue Integrity at the Minneapolis Convention Center, October 12–14, 2025 MINNEAPOLIS,...

error: Content is protected !!